The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Patient (pt) population and radiation therapy (RT) type in the long-term phase 3 double-blind, placebo (PBO)-controlled ATLAS study of apalutamide (APA) added to androgen deprivation therapy (ADT) in high-risk localized or locally advanced prostate cancer (HRLPC).
 
Howard M. Sandler
Stock and Other Ownership Interests - Radiogel
Consulting or Advisory Role - Janssen
Other Relationship - Caribou Publishing
 
Stephen J. Freedland
Employment - Genomic Health (I)
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bayer; Clovis Oncology; Dendreon; Exact Sciences; Ferring; Janssen Biotech; Merck; Myovant Sciences; Pfizer; Sanofi
Speakers' Bureau - AstraZeneca; Sanofi
Research Funding - Bayer (Inst); Diasorin; GenomeDx (Inst); Janssen Biotech (Inst); MDxHealth (Inst); Merck; Myriad Genetics (Inst); OPKO Diagnostics (Inst); Progenika (Inst)
Travel, Accommodations, Expenses - Sanofi
 
Neal D. Shore
Consulting or Advisory Role - Abbvie; Amgen; Astellas Pharma; AstraZeneca; Bayer; Boston Scientific; Bristol-Myers Squibb/Sanofi; CG Oncology; CG Oncology; Clovis Oncology; Dendreon; Exact Imaging; Exact Sciences; FerGene; Ferring; Foundation Medicine; Genesis Cancer Care; Genzyme; Genzyme; InVitae; Janssen Scientific Affairs; MDxHealth; Medivation/Astellas; Merck; Myovant Sciences; Myriad Genetics; Nymox; Pacific Edge Biotechnology; Peerview; Pfizer; Phosphorus; Propella Therapeutics; Sanofi; Sesen Bio; Speciality Networks; Tolmar; Urogen pharma
Speakers' Bureau - Astellas Pharma; AstraZeneca; Bayer; Clovis Oncology; Dendreon; Foundation Medicine; Guardant Health; Janssen; Merck; Pfizer
Research Funding - Abbvie; Amgen; Astellas Pharma; AstraZeneca; Bayer; Boston Scientific; Bristol-Myers Squibb/Pfizer; Clovis Oncology; Dendreon; Exact Imaging; Ferring; Foundation Medicine; InVitae; Janssen; MDxHealth; Merck; Myovant Sciences; Myriad Genetics; Nymox; Pfizer; Sanofi; Sesen Bio; Tolmar
 
Matthew Raymond Smith
Consulting or Advisory Role - Amgen; Astellas Pharma; Bayer; Janssen Oncology; Lilly; Novartis; Pfizer
Research Funding - Bayer (Inst); ESSA (Inst); Janssen Oncology (Inst); Lilly (Inst); ORIC Pharmaceuticals (Inst)
 
Rosamerlinda S. Rosales
Employment - Janssen Oncology
Stock and Other Ownership Interests - Johnson & Johnson
 
Sabine D. Brookman-May
Employment - Janssen Research & Development
Leadership - Janssen Research & Development
Stock and Other Ownership Interests - Johnson & Johnson
 
David P. Dearnaley
Patents, Royalties, Other Intellectual Property - Abiraterone acetate was developed at The Institute of Cancer Research, which therefore has a commercial interest in the development of this agent. Professor Dearnaley is on the Institute’s Rewards to Inventors list for abiraterone acetate. (Inst); Patent issued EP1933709B1 (location and stabilisation device)
Travel, Accommodations, Expenses - Janssen Oncology
 
Adam P. Dicker
Stock and Other Ownership Interests - Oncohost
Consulting or Advisory Role - Accordant; Alcimed; CVS; Cybrexa Therapeutics; Deallus; EMD Serono; Genentech; Hengrui Pharmaceutical; IBA; Janssen; Oncohost; Orano Med; Roche; Third Bridge
Patents, Royalties, Other Intellectual Property - We recently filed a patient "DOPED BEO COMPOUNDS FOR OPTICALLY STIMULATED LUMINESCENCE (OSL) AND THERMOLUMINESCENCE (TL) RADIATION DOSIMETRY"
Expert Testimony - Wilson Sonsini
Travel, Accommodations, Expenses - Oncohost
Other Relationship - European Commission
(OPTIONAL) Uncompensated Relationships - Dreamit Ventures; Google
 
Michael R. McKenzie
Honoraria - Bayer
Research Funding - Janssen Oncology
(OPTIONAL) Uncompensated Relationships - Janssen-Ortho
 
Alberto Bossi
Honoraria - Astellas Pharma; Ferring; Ipsen; Myovant Sciences
Speakers' Bureau - Astellas/Agensys; Ipsen
 
Anders Widmark
No Relationships to Disclose
 
Thomas Wiegel
Honoraria - Ipsen; Janssen-Cilag; Recordati
Consulting or Advisory Role - Janssen-Cilag
(OPTIONAL) Uncompensated Relationships - European Association of Urology
 
Jason L. Martin
Employment - Johnson & Johnson
Stock and Other Ownership Interests - Johnson & Johnson
 
Branko Miladinovic
Employment - Janssen Research & Development
Stock and Other Ownership Interests - Johnson & Johnson
 
Jennifer Anne Whalen
Employment - Janssen Oncology
Stock and Other Ownership Interests - Janssen Oncology
Research Funding - Janssen Oncology
 
Marika Ciprotti
Employment - Bristol-Myers Squibb; Janssen
Stock and Other Ownership Interests - Bristol-Myers Squibb; Janssen
 
Sharon McCarthy
Employment - Janssen Oncology
Stock and Other Ownership Interests - Johnson and Johnson
 
Suneel Mundle
Employment - Janssen
Stock and Other Ownership Interests - Johnson & Johnson
 
Bertrand F. Tombal
Honoraria - Amgen; Astellas Pharma; Bayer; Ferring; Janssen; Myovant Sciences; Pfizer; Sanofi
Consulting or Advisory Role - Astellas Pharma; Bayer; Ferring; Janssen; Myovant Sciences; Pfizer/Astellas; Sanofi; Steba Biotech; Takeda
Speakers' Bureau - Amgen; Astellas Pharma; Astellas Pharma; Janssen
Research Funding - Ferring (Inst)
Expert Testimony - Steba Biotech
Travel, Accommodations, Expenses - Amgen; Astellas Pharma; Bayer; Ferring; Janssen; Sanofi
 
Felix Y Feng
Stock and Other Ownership Interests - Artera
Consulting or Advisory Role - Astellas Pharma; Bayer; BlueStar Genomics; Bristol Myers Squibb; Exact Sciences; Foundation Medicine; Janssen Biotech; Myovant Sciences; Novartis; Roivant; SerImmune; Varian Medical Systems
Research Funding - Zenith Epigenetics